AOGIN 2017 Tokyo Meeting

Oral Session 1: Head and neck cancer

October 18 (Wed.) 14:40-15:10 ROOM 2 (503BC)

HPV-related squamous cell carcinoma of the lacrimal sac: a case successfully treated with chemo-radiation therapy

Takashi Toshiyasu

(The Cancer Institute Hospital of JFCR, Radiation Oncology, Japan)

Evaluation of oropharyngeal cancer according to the 8th edition of AJCC TNM staging system

Ichiro Ota

(Nara Medical University, Japan)

Serological and molecular detection of HPV infections of a cohort of oral and oropharyngeal cancer patients in Sri Lanka

Asanga Wathupola

(Department of Zoology and Environment Sciences, University of Colombo, Sri Lanka)

Oral Session 2: Health education and Society

October 18 (Wed.) 15:10-16:00 ROOM 2 (503BC)

Importance of advocacy lectures on women's awareness and attitude on cervical cancer screening and HPV vaccination

Jimmy Billod

(Baguio General Hospital and Medical Centre, Philippine)

The role of Japanese male in HPV-related disease prevention: A large-scale questionnaire in Japan

Yukio Suzuki

(Department of Obstetrics and Gynecology, Yokohama City University, Japan)

The acceptance of the WeChat official account as a health education platform and its effect on cervical diseases prevention

Xia Tao

(Department of Obstetrics and Gynecology, Peking University First Hospital, China)

The effects of multidisciplinary treatment (MDT) on management of patients diagnosed with cervical squamous intraepithelial lesion (SIL) and HPV infection

Xiying Ren

(Department of Obstetrics and Gynecology, Peking University First Hospital, China)

The epidemiologic and economic impact of a nonavalent (6/11/16/18/31/33/45/52/58) human papillomavirus vaccination program in Taiwan

Amit S. Kulkarni

(Merck & Co., Inc.)

Oral Session 3: Screening

October 18 (Wed.) 17:20-18:30 ROOM 2 (503BC)

Evidence for clinical application of extended HPV genotyping in cervical cancer screening paradigms: A systematic review

Jeff Andrews

(BD - Becton Dickinson)

Population based cervix cancer screening - Combined Hr-HPV DNA and visual test(Via/Vili) in a low resource setting

Malliga J. Subramanian

(Cancer Institute(Wia), India)

Clinical performance of HPV testing and via in primary, combination, and sequential cervical cancer screening in inner Mongolia, China

Margaret Z. Wang

(Pritzker School of Medicine, University of Chicago, USA)

Accuracy of triage strategies for human papillomavirus DNA-positive women in low-resource settings: A cross-sectional study

Margaret Z. Wang

(Pritzker School of Medicine, University of Chicago, USA)

A real-world population-based multi-center randomized trial for cervical cancer screening in Urban China

Yu-Qian Zhao

(Department of Cancer Epidemiology, National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Sciences, China)

TBA

Vijaya Srinivas

Prevalence of cervical cancer and precancer lession (VIA positive) along with cryotherapy as treatment for VIA positive on women joining "See-and-Treat Program" Female Cancer Program Faculty of Medicine Universitas Indonesia from 2004 - 2016 in Jakarta-Indonesia

Laila Nuranna

(Division of Gynecologic Oncology Department of Obstetric and Gynecology Cipto Mangungkusumo Hospital Jakarta, Indonesia)

Oral Session 4: New Diagnostic tool

October 19 (Thu.) 9:00-9:20 ROOM 2 (503BC)

PET-CT vs. contrast CT in detecting residual disease following neo-adjuvant chemotherapy in ovarian cancer

Elaine Y. P. Lee

(Department of Diagnostic Radiology, Queen Mary Hospital, The University of Hong Kong, Hong Kong)

Texture Analysis of Diffusion-Weighted and T2-Weighted MRI and associations with nodal metastatic status in patients with cervical cancer

Jose A. Perucho

(The University of Hong Kong, Hong Kong)

Oral Session 5: Colposcopy and CIN

October 19 (Thu.) 10:30-11:50 ROOM 2 (503BC)

Evidence for clinical application of extended HPV genotyping in cervical cancer screening paradigms: A systematic review

Jeff Andrews

(BD - Becton Dickinson)

Whole-genome analysis of HPV52/58 isolated from Japanese women with cervical intraepithelial neoplasia and invasive cervical cancer

Iwao Kukimoto

(Pathogen Genomics Center, National Institute of Infectious Diseases, Japan)

If persistent HPV infection causes disease, why are we not measuring It?

Jeff Andrews

(BD - Becton Dickinson)

The relationship between age and pathological regression in the excised cervix specimen by a loop electrosurgical excision procedure (LEEP) in the treatment of CIN2

Lu Jiang

(Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing, China)

The distribution of squamous intraepithelial lesion (SIL) in the cervix of uterine

Tong Xie

(Department of Obstetrics and Gynaecology, Peking University First Hospital, Beijing, China)

Patients with high grade squamous intraepithelial lesion are at higher risk of developing skip lesion than those with low grade lesion

Fangda Leng

(Peking University First Hospital, China)

Carbon dioxide laser vaporization for high grade CIN - Treatment efficacy and risk factors of recurrence -

Kouichiro Kawano

(Department of Obstetrics and Gynecology Kurume University, School of Medicine, Japan)

Implementation of screen and treat (via & cryo) programme in the state of up, India - A 2 year experience

Uma Singh

(KG Medical University, Lucknow, India)

Oral Session 6: Cervix, Vagina, Vulva and STI

October 19 (Thu.) 11:00-11:50 ROOM 1 (501AB)

Crosswalking asian guidelines on the management of vaginal discharge and the management of STI

Jeff Andrews

(BD - Becton Dickinson)

Tenofovir-induced acute kidney injury in HIV-infected pregnant woman

Stella Kawilarang

(Department of Obstetrics and Gynaecology Faculty of Medicine Universitas Udayana, Sanglah General Hospital Bali Indonesia)

Vaginal and vulvar intra-epithelial neoplasia in young women

Suzanne Garland

(Department of Microbiology Infectious Diseases, The Royal Women's Hospital, Murdoch Childrens Research Institute, Department of Obstetrics and Gynaecology, University of Melbourne, Australia)

A new ablation therapy using liquid phenol for cervical and vaginal intraepithelial lesions

Toshiyuki Sasagawa

(Department of Obstetrics and Gynecology, Kanazawa Medical University, Japan)

Improving surgical outcome by using reconstructive approach after vulvectomy for cancer vulva

Arun Kumar Singh

(Dept of Plastic Surgery, KG Medical University, India)

Oral Session 7: HPV vaccine

October 19 (Thu.) 15:50-17:00 ROOM 1 (501AB)

Effects of national human papillomavirus vaccination program in Japan

Manako Yamaguchi

(Niigata University, Japan)

Effectiveness, immunogenicity, and safety of gardasil™ in pre-adolescents and adolescents -10 years of follow-up

Ole-Erik Iversen

(Department of Obstetrics and Gynecology, Haukeland University Hospital, University of Bergen, Bergen, Norway)

Long-term effectiveness of gardasil™ among adult women in Colombia

Rita Das

(Merck & Co., Inc.)

Poster Session

ROOM 503A

Spontaneous uterine perforation and sepsis due to pyometra complicated by choriocarcinoma: A case report

Murthy Mutmainah

(Association Of Obstetric And Gynecology Of Indonesia, Indonesia)

Attitudes regarding HPV vaccinations of children among mothers with adolescent daughters in Korea

Sung Taek Park

(The Hallym University of Korea, Korea)

Early-stage clear cell carcinoma of the cervix: A case report and review of literature

Kristine I. Alvaro

(Philippine General Hospital, Philippines)

Human papillomavirus genotypes identified in high-grade CIN and invasive cervical cancer in Japanese women

Jinichi Sakamoto

(Kanazawa Medical Univercity, Japan)

Genes encoding neuropeptide receptors are epigenetic markers in patients with head and neck cancer: a site-specific analysis

Kiyoshi Misawa

(Hamamatsu University School of Medicine, Otolaryngology / Head and Neck Surgery, Japan)

Maintenance of TERRA in cervical cancer cells

Joong Sub Choi

(Division of Gynecologic Oncology and Gynecologic Minimally Invasive Surgery)